Veeva CRM empowers field teams with the information they need for
greater productivity
PLEASANTON, Calif.--(BUSINESS WIRE)--
Veeva
Systems (NYSE:VEEV) today announced that Menarini, an Italian-based
biopharmaceutical company, selected Veeva
CRM to improve commercial execution throughout its over-the-counter
(OTC) business. Veeva CRM will provide Menarini field teams with
real-time customer insights to drive more effective and efficient
engagement with pharmacies.
“We wanted to standardize on a single CRM solution that could scale and
support Menarini’s rapid growth,” said Maurizio Luongo, corporate OTC
business director at Menarini. “Moving to Veeva CRM will help us better
coordinate field activities as the company expands into new markets.”
Veeva CRM’s order management capabilities enable sales reps to create
and price orders directly from the pharmacy. Customer insights are
delivered at the point of sale based on interactions, orders, and
product visibility to drive effective negotiation. Menarini’s field reps
can enter orders in minutes rather than hours, improving efficiency and
sales productivity.
“There has been significant momentum in Italy as more life sciences
organizations adopt cloud technology to optimize field engagement,” said
Jan van den Burg, vice president of commercial strategy at Veeva Europe.
“We’re proud to partner with Menarini to help enhance their commercial
operations and support the company’s future growth.”
Additional Information
For more information on Veeva CRM, visit: veeva.com/CRM
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veevasystems on Twitter: twitter.com/veevasystems
Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 650 customers, ranging from the
world's largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices throughout
North America, Europe, Asia, and Latin America. For more information,
visit veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on Form
10-Q for the period ended July 31, 2018. This is available on the
company’s website at veeva.com
under the Investors section and on the SEC’s website at sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20181106005183/en/
Veeva Systems
Roger Villareal, 925-264-8885
roger.villareal@veeva.com
or
Lisa
Barbadora, 610-420-3413
pr@veeva.com
Source: Veeva Systems